Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
E610131-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $600.90 | |
E610131-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,000.90 |
Synonyms | Enerisant|Enerisant [INN]|UNII-E2Y97PQY3A|E2Y97PQY3A|1152747-82-4|Methanone, (1-(4-(3-((2R)-2-methyl-1-pyrrolidinyl)propoxy)phenyl)-1H-pyrazol-4-yl)-4-morpholinyl-|SCHEMBL1179419|GTPL11293|IABXVJILZYNSTM-GOSISDBHSA-N|HY-17610|CS-0014688|Q27276798|[1-[4-[3 |
---|---|
Specifications & Purity | 98% |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | ANTAGONIST |
Mechanism of action | Antagonist of H 3 receptor |
Product Description |
Enerisant (TS-091) is a potent, highly selective, competitive active histamine H3 receptor antagonist/inverse agonist with IC50s of 2.89 nM and 14.5 nM against human and rat histamine H3 receptors, respectively.
|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | [1-[4-[3-[(2R)-2-methylpyrrolidin-1-yl]propoxy]phenyl]pyrazol-4-yl]-morpholin-4-ylmethanone |
---|---|
INCHI | InChI=1S/C22H30N4O3/c1-18-4-2-9-24(18)10-3-13-29-21-7-5-20(6-8-21)26-17-19(16-23-26)22(27)25-11-14-28-15-12-25/h5-8,16-18H,2-4,9-15H2,1H3/t18-/m1/s1 |
InChi Key | IABXVJILZYNSTM-GOSISDBHSA-N |
Canonical SMILES | C[C@@H]1CCCN1CCCOc1ccc(cc1)n1ncc(c1)C(=O)N1CCOCC1 |
Isomeric SMILES | C[C@@H]1CCCN1CCCOC2=CC=C(C=C2)N3C=C(C=N3)C(=O)N4CCOCC4 |
PubChem CID | 42601503 |
Molecular Weight | 398.50 |
PubChem CID | 42601503 |
---|---|
CAS Registry No. | 1152747-82-4 |
GPCRdb Ligand | enerisant |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
G2410108 | Certificate of Analysis | May 27, 2024 | E610131 |
G2410109 | Certificate of Analysis | May 27, 2024 | E610131 |
G2410348 | Certificate of Analysis | May 27, 2024 | E610131 |
G2410349 | Certificate of Analysis | May 27, 2024 | E610131 |
1. Hino N, Marumo T, Kotani M, Shimazaki T, Kaku-Fukumoto A, Hikichi H, Karasawa JI, Tomishima Y, Komiyama H, Tatsuda E et al.. (2020) A Novel Potent and Selective Histamine H3 Receptor Antagonist Enerisant: In Vitro Profiles, In Vivo Receptor Occupancy, and Wake-Promoting and Procognitive Effects in Rodents.. J Pharmacol Exp Ther, 375 (2): (276-285). [PMID:32862143] |